| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
53,543,000 |
| Market
Cap: |
11.50(B) |
| Last
Volume: |
464,634 |
Avg
Vol: |
475,567 |
| 52
Week Range: |
$164.52 - $273.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 456 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
| Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
5 |
| Total Shares Sold |
1,636 |
31,084 |
49,996 |
92,833 |
| Total Sell Value |
$374,194 |
$7,621,206 |
$11,292,577 |
$21,658,880 |
| Total People Sold |
2 |
6 |
6 |
8 |
| Total Sell Transactions |
2 |
11 |
16 |
28 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Foster James C |
Chairman, President and CEO |
• • – |
2021-05-07 |
4 |
S |
$341.80 |
$2,573,770 |
D/D |
(7,500) |
216,072 |
|
-28% |
|
| Kochevar Deborah Turner |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
355 |
7,083 |
|
- |
|
| Milne George M Jr |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
662 |
29,079 |
|
- |
|
| Mackay Martin |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
574 |
9,599 |
|
- |
|
| Wallman Richard F |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
574 |
32,289 |
|
- |
|
| Bertolini Robert J |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
603 |
29,737 |
|
- |
|
| Reese C Richard |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
589 |
63,478 |
|
- |
|
| Llado George |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
530 |
953 |
|
- |
|
| Massaro George |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
355 |
5,726 |
|
- |
|
| Andrews Nancy C |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
355 |
1,220 |
|
- |
|
| Massaro George |
Director |
• • – |
2021-05-06 |
4 |
S |
$336.06 |
$1,135,561 |
D/D |
(3,370) |
5,371 |
|
-31% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-05-04 |
4 |
AS |
$340.01 |
$1,123,718 |
D/D |
(3,305) |
14,862 |
|
27% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-05-04 |
4 |
OE |
$144.67 |
$478,134 |
D/D |
3,305 |
18,167 |
|
- |
|
| Knell Michael Gunnar |
CSVP&Chief Accounting Officer |
• • – |
2021-05-01 |
4 |
D |
$332.45 |
$30,918 |
D/D |
(93) |
3,959 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-04-22 |
4 |
AS |
$330.00 |
$1,268,850 |
D/D |
(3,845) |
14,862 |
|
35% |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-04-22 |
4 |
OE |
$109.34 |
$420,412 |
D/D |
3,845 |
18,707 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-04-15 |
4 |
AS |
$320.00 |
$640,000 |
D/D |
(2,000) |
14,862 |
|
33% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-04-06 |
4 |
AS |
$298.00 |
$5,541,104 |
D/D |
(18,311) |
29,060 |
|
36% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-04-06 |
4 |
OE |
$88.05 |
$2,083,695 |
D/D |
18,311 |
34,976 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-04-05 |
4 |
AS |
$298.00 |
$297,702 |
D/D |
(999) |
29,060 |
|
37% |
|
| Girshick Birgit |
Corporate Executive VP |
• • – |
2021-04-05 |
4 |
OE |
$88.05 |
$87,962 |
D/D |
999 |
30,059 |
|
- |
|
| Girshick Birgit |
Corporate Executive VP & COO |
• • – |
2021-03-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
28,710 |
|
- |
|
| Milne George M Jr |
Director |
• • – |
2021-03-01 |
4 |
S |
$290.01 |
$1,023,730 |
D/D |
(3,530) |
28,417 |
|
-33% |
|
| Milne George M Jr |
Director |
• • – |
2021-03-01 |
4 |
OE |
$52.29 |
$184,584 |
D/D |
3,530 |
31,947 |
|
- |
|
| Smith David Ross |
Corporate Executive VP & CFO |
• • – |
2021-03-01 |
4 |
S |
$290.12 |
$1,266,647 |
D/D |
(4,366) |
16,862 |
|
-33% |
|
2069 Records found
|
|
Page 14 of 83 |
|
|
6.83 (3.08%) 
